• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Medtronic has a new chief medical officer for robotics, digital tech

Medtronic has a new chief medical officer for robotics, digital tech

September 12, 2024 By Sean Whooley

James Porter Medtronic chief medical officer for robotic surgical technologies and digital technologies (1)
Dr. James Porter. [Image courtesy of Medtronic]
Medtronic (NYSE: MDT) announced that Dr. James Porter joined the company as chief medical officer of Robotic Surgical Technologies and Digital Technologies.

Porter joins the unit within the Surgical business as part of the Medical Surgical portfolio at the medtech giant. A practicing urologic surgeon, Porter boasts more than 5,000 robotic-assisted procedures under his belt. Medtronic called Porter a “recognized leader” among the global surgical community. The company said he’s one of the top five robotic surgery practitioners in the U.S.

The new CMO specializes in prostate, kidney cancer and urinary constructive procedures, according to a news release. His track record includes advancing techniques for treating kidney tumors and testicular cancer in young men. He will continue to practice surgery on a part-time basis at Providence Swedish in Seattle.

As CMO, Medtronic expects Porter to play a key role in driving focus on patients and robotic and digital innovation. His responsibilities include managing the strategic direction of clinical evidence plans, physician and society engagements.

Medtronic develops the Hugo robot-assisted surgery system. Hugo is a modular, multi-quadrant platform designed for various surgical procedures. It features wristed instruments, 3D visualization and surgical video capture options in Touch Surgery Enterprise. Medtronic first unveiled Hugo in September 2019,

The company continues to build on the Hugo platform, adding more clinical studies earlier this year to expand its indications to hernia and gynecology.

Commentary from Porter and Medtronic officials

On his appointment, Porter said: “I went into medicine because I want to help people and I am absolutely thrilled to now expand the impact on patients to a global scale with Medtronic, a company that I have always admired. Tens of millions of patients around the world still lack access to minimally invasive surgical care and I’m excited about our opportunity at Medtronic to make a big impact for humanity. Surgery is fast evolving, due in large part to robotic and digital technologies, and Hugo and Touch Surgery are leading the way.”

Rajit Kamal, GM and VP of Robotic Surgical Technologies at Medtronic, added: “Medtronic is privileged to welcome such a renowned physician to our business, and we look forward to Dr. Porter’s contributions as CMO of our robotic and digital divisions as we execute our strategy to scale and continually advance our capabilities to meet customer needs and positively impact patients around the world.”

Filed Under: Artificial Intelligence (AI), Business/Financial News, Digital Health, Featured, Health Technology, Machine Learning (ML), Robotic-Assisted, Software / IT, Surgical, Surgical Robotics Tagged With: ambulatory surgery centers (ASCs), Medtronic, Personnel Moves

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy